14-day Premium Trial Subscription Sign Up For FreeGet Free

Acceleron Pharma Inc. Stock Forecast NASDAQ:XLRN

$178.75 (0%)

Volume: 0

Closed: Nov 29, 2021

Hollow Logo Score: 0.000

Acceleron Pharma Inc. Stock Forecast

$178.75 (0%)

Volume: 0

Closed: Nov 29, 2021

Score Hollow Logo 0.000
Which way will XLRN go? Request
Stop-loss: $172.31 (-3.60%)
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Acceleron Pharma Inc. stock holds an RSI14 at 77 and is currently being overbought on RSI. This does not have to be a sell signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Red day on Monday for Acceleron Pharma Inc. stock after losing 0%
(Updated on Nov 29, 2021)


Buy or Hold candidate since 2021-11-16 Gain 2.74%

No changes to the price of Acceleron Pharma Inc. stock on the last trading day (Monday, 29th Nov 2021). During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75. The price has been going up and down for this period, and there has been a 3.26% gain for the last 2 weeks.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $173.24 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 29.27% during the next 3 months and, with a 90% probability hold a price between $223.95 and $279.47 at the end of this 3-month period.

Signals & Forecast

The Acceleron Pharma Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $178.88. On a fall, the stock will find some support from the long-term average at approximately $174.75. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, November 18, 2021, and so far it has fallen -0.52%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Tuesday, November 16, 2021 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Tuesday, November 16, 2021 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, September 07, 2021 with a target of $132.98. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss

Acceleron Pharma Inc. finds support from accumulated volume at $175.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 0%

Our recommended stop-loss: $172.31 (-3.60%) (This stock has low daily movements and this gives low risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from a pivot top found 6 days ago.)

Is Acceleron Pharma Inc. stock A Buy?

Acceleron Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Acceleron Pharma Inc. of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$178.75 $178.75 (Undervalued)
Hold/Accumulate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 06, 2021 "Jefferies Financial Group" gave "" rating for XLRN. The price target was changed from $175.29 to 1.0%.

Volatility and Risk
Daily Average Volatility: 0 %
Overall Risk: Very High High Medium Low Very Low
Volatility
0 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $178.87
Price: $178.75
Support: $175.36

XLRN Insider Trading Show all Trades

INSIDER POWER

0.248

Last 100 transactions
Buy: 191 500 | Sell: 771 918 (Shares)
Date Action Amount Person Type
Nov 19, 2021 Sell 3 222 Zakrzewski Joseph S Option to Purchase Common Stock
Nov 19, 2021 Sell 34 499 Zakrzewski Joseph S Common Stock
Nov 19, 2021 Sell 3 222 Malik Kemal Option to Purchase Common Stock
Nov 19, 2021 Sell 1 622 Malik Kemal Common Stock
Nov 19, 2021 Sell 1 848 Hite Christopher Option to Purchase Common Stock
Show all Insider Trades
INSIDER POWER

0.248

Last 100 transactions
Buy: 191 500 | Sell: 771 918 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 178.75 .
178.75 .
178.75 .
Current price: 178.75
Support 178.75 .
178.75 .
178.75 .

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 182.78 2.25 %
179.68 0.52 %
178.87 0.0671 %
Current price 178.75
Support 175.36 -1.90%
173.78 -2.78%
172.10 -3.72%

Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT